Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,998 | -349,848 | -258,295 | -169,866 | -80,481 |
| Depreciation Amortization | 4,460 | 14,703 | 10,904 | 7,204 | 2,972 |
| Accounts payable and accrued liabilities | 795 | -3,717 | -170 | 2,600 | 6,497 |
| Other Working Capital | 9,612 | -19,112 | -12,326 | -398 | 5,486 |
| Other Operating Activity | 13,201 | 83,555 | 57,107 | 30,396 | 5,057 |
| Operating Cash Flow | $-74,930 | $-274,419 | $-202,780 | $-130,064 | $-60,469 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,082 | -127,987 | 10,819 | 13,303 | 7,003 |
| PPE Investments | -27,347 | -13,065 | -2,662 | -15,128 | -7,083 |
| Purchase Of Investment | -1,000 | N/A | N/A | 0 | N/A |
| Sale Of Investment | 14,345 | 56,166 | 44,759 | 44,159 | 31,925 |
| Purchase Sale Intangibles | -21,229 | N/A | N/A | 0 | 0 |
| Other Investing Activity | -21,229 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-69,313 | $-84,886 | $52,916 | $42,334 | $31,845 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 338,500 | 40,000 | 40,000 | 40,000 |
| Common Stock Issued | 74 | 169,991 | 142,058 | 99,458 | 1,121 |
| Other Financing Activity | -372 | -3,048 | -2,568 | -2,624 | -2,624 |
| Financing Cash Flow | $-298 | $505,443 | $179,490 | $136,834 | $38,497 |
| Exchange Rate Effect | -175 | 48 | -17 | -61 | -109 |
| Beginning Cash Position | 181,280 | 35,094 | 35,094 | 35,094 | 35,094 |
| End Cash Position | 36,564 | 181,280 | 64,703 | 84,137 | 44,858 |
| Net Cash Flow | $-144,716 | $146,186 | $29,609 | $49,043 | $9,764 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,930 | -274,419 | -202,780 | -130,064 | -60,469 |
| Capital Expenditure | -27,347 | -33,563 | -23,160 | -15,128 | -7,083 |
| Free Cash Flow | -102,277 | -307,982 | -225,940 | -145,192 | -67,552 |